News & Media

Drug-related pneumonitis occurred among 18% of patients receiving osimertinib for advanced epidermal growth factor receptor mutation-positive non-small cell lung cancer, according to study results published in CHEST.

Discoveries & Impact highlights select scientific discoveries across the Department of Internal Medicine...

The Department of Internal Medicine is pleased to welcome the following new faculty, staff members, and postdoctoral associates who joined us in December 2022...

Three Department of Internal Medicine staff are set to retire. Kathleen Marcucio from the Section of Endocrinology & Metabolism retired on December 31, 2022. Susan Ardito from the Section of Pulmonary, Critical Care & Sleep Medicine (Yale-PCCSM), and Elizabeth “Beth” Porter from the Section of General Internal Medicine retire in January 2023.

A new analysis of how far Americans have to travel to receive COVID-19 oral treatments like Paxlovid reveals stubborn discrepancies in health care access.

Both ION and the Monarch technology are being used for patients who have already been screened through low-dose CT scans in whom nodules are discovered. A lung nodule is an area of abnormality on the lung that is limited in area, said Dr. Sanket Thakore, a pulmonologist with Yale Medicine.

Sleep is vital -- your body needs sleep not only to rest, but also to regulate your metabolism and brain function. But if you're anything like me, your brain feels anything but restful when you sleep, because it's too busy cooking up wild and strange scenarios in the form of dreams. Though it's easy to understand why we have to go to sleep each night, it's much more difficult to explain why we dream and how to interpret what exactly those dreams mean, especially if they're outlandish or perhaps even scary.

In case you missed it: Yale Department of Internal Medicine’s most read stories throughout 2022.

The 2022 Yale Life Science Pitchfest held on December 8, 2022 featured 31 Yale faculty innovators presenting breakthrough research projects in therapeutics, medical devices, and digital health to a crowd of over 325 people from 120+ companies, including 14 industry judges.